Ashley KE - Search Results

1

American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease.

Hasbani NR, Ligthart S, Brown MR, Heath AS, Bebo A, Ashley KE, Boerwinkle E, Morrison AC, Folsom AR, Aguilar D, de Vries PS. Hasbani NR, et al. Among authors: ashley ke. Circulation. 2022 Mar 15;145(11):808-818. doi: 10.1161/CIRCULATIONAHA.121.053730. Epub 2022 Jan 31. Circulation. 2022. PMID: 35094551 Free PMC article.

2

Ischemic heart disease in women.

Ashley KE, Geraci SA. Ashley KE, et al. South Med J. 2013 Jul;106(7):427-33. doi: 10.1097/SMJ.0b013e31829b9eab. South Med J. 2013. PMID: 23820324 Review.

3

Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention.

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2020 Aug;96(2):309-310. doi: 10.1002/ccd.29170. Catheter Cardiovasc Interv. 2020. PMID: 32797736 No abstract available.

4

Physical Activity, Inflammation, Coronary Artery Calcification, and Incident Coronary Heart Disease in African Americans: Insights From the Jackson Heart Study.

Kamimura D, Cain-Shields LR, Clark D, Oshunbade AA, Ashley KE, Guild CS, Loprinzi PD, Newton R, Blaha MJ, Suzuki T, Butler J, Hall JE, Correa A, Hall ME. Kamimura D, et al. Among authors: ashley ke. Mayo Clin Proc. 2021 Apr;96(4):901-911. doi: 10.1016/j.mayocp.2020.09.042. Epub 2021 Mar 10. Mayo Clin Proc. 2021. PMID: 33714604 Free PMC article.

5

Ticagrelor monotherapy: When is mono-antiplatelet therapy (MAPT) equivalent or better?

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2020 Dec;96(7):1379-1380. doi: 10.1002/ccd.29411. Catheter Cardiovasc Interv. 2020. PMID: 33306876

6

Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2021 Apr 1;97(5):795-796. doi: 10.1002/ccd.29659. Catheter Cardiovasc Interv. 2021. PMID: 33851782 No abstract available.

7

Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2021 Mar;97(4):579-580. doi: 10.1002/ccd.29573. Catheter Cardiovasc Interv. 2021. PMID: 33721413 No abstract available.

8

Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2022 Jul;100(1):83-84. doi: 10.1002/ccd.30315. Catheter Cardiovasc Interv. 2022. PMID: 35819146 No abstract available.

9

Distal Trans-radial Access Compared to Conventional Trans-radial Access in Coronary Interventions: A Meta-analysis.

Talha KM, Waqar E, Ashley KE, Cohen MG, Lemor A, McMullan MR, Winscott JG, Hernandez GA. Talha KM, et al. Among authors: ashley ke. Crit Pathw Cardiol. 2022 Dec 1;21(4):176-178. doi: 10.1097/HPC.0000000000000304. Epub 2022 Nov 1. Crit Pathw Cardiol. 2022. PMID: 36413395

10

Radial access and risk guided use of bivalirudin?

Ashley KE, Hillegass WB. Ashley KE, et al. Catheter Cardiovasc Interv. 2020 Nov;96(6):1249-1250. doi: 10.1002/ccd.29358. Catheter Cardiovasc Interv. 2020. PMID: 33217186 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page